Gene Therapy. Redefined.
We are a biopharmaceutical gene therapy company developing life-changing gene therapies for conditions affecting millions of people around the world. Our mission is to make gene therapies accessible – not just for the few – but for the many.
In Sanskrit, Kriya (“kree-yah”) means “action.” When we succeed, Kriya – in every language – will mean “gene therapy for all in need.”
In the News
Therapeutic Program Areas
Kriya is targeting diseases that impact millions of people worldwide and represent areas of high unmet need. We target validated biological pathways with innovative gene therapy approaches that have the potential to deliver transformative benefits.
Kriya is led by a team of exceptional drug developers, including pioneers in the fields of genetic medicine, clinical research, and complex biologics.
We are located in Research Triangle Park, North Carolina and Palo Alto, California.
Our Investors
We are backed by leading healthcare and technology investors who are committed to our goal of building the world’s leading gene therapy biopharmaceutical company. Since our founding in 2019, Kriya has raised over $600 million in investments.
